Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep 4;11(Suppl 10):0.
doi: 10.1186/s12919-017-0077-6. eCollection 2017.

Proceedings from the CIHLMU 5th Infectious Diseases Symposium 2016 "Drug Resistant Tuberculosis: Old Disease - New Challenge"

Celso Khosa  1   2 , Krutarth Patel  1   3 , Karlygash Abdiyeva  1   4 , Nurkeldi Turebekov  1   4 , Bettina Prüller  1 , Norbert Heinrich  1   5   6
Affiliations

Proceedings from the CIHLMU 5th Infectious Diseases Symposium 2016 "Drug Resistant Tuberculosis: Old Disease - New Challenge"

Celso Khosa et al. BMC Proc. .

Abstract

The 5th CIHLMU Infectious Disease Symposium, Munich, Germany, March 12, 2016 brought together Tuberculosis Experts from developed and low middle-income countries to discuss the control of drug resistance Tuberculosis. The meeting featured 9 presentations: Tuberculosis history and current scenario, Tuberculosis and migration - current scenario in Germany, Mechanism of Tuberculosis resistance development, Epidemiology of resistance - transmission vs. new generation of resistance, The impact of diagnostic in patients beyond - sensitivity and specificity, The Bangladesh regimen - new hope trough old drugs, New drugs and regimens - an overview on studies and Multi and Extensively Drug Resistant Tuberculosis from Europe. The presentations were followed by a panel discussion. Serious Multidrug Resistance epidemic in some countries may jeopardize the progress in Tuberculosis control. In this meeting epidemiology, mechanism, immigration and screening, diagnosis, research and treatment of drug resistant tuberculosis were discussed.

Keywords: Diagnosis; Extensively drug-resistant tuberculosis; Multi-drug resistant tuberculosis; Therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Symposium flyer
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. WHO. Global Tuberculosis Programme . Global tuberculosis report 2015. Geneva: World Health Organization; 2015.
    1. Daniel TM. The history of tuberculosis. Respir Med. 2006;100(11):1862–1870. doi: 10.1016/j.rmed.2006.08.006. - DOI - PubMed
    1. Crofton J, Mitchison DA. Streptomycin resistance in pulmonary tuberculosis. Br Med J. 1948;2(4588):1009–1015. doi: 10.1136/bmj.2.4588.1009. - DOI - PMC - PubMed
    1. Fiebig L, Hauer B, Brodhun B, Altmann D, Haas W. Tuberculosis in Germany: a declining trend coming to an end? Eur Respir J. 2016;47(2):667–670. doi: 10.1183/13993003.01410-2015. - DOI - PubMed
    1. Institute TRK . RKI report on the epidemiology of tuberculosis in Germany for 2015. 2016.

LinkOut - more resources